CMS Open Payments · Program Year 2024
AmerisourceBergen Drug Corporation
AmerisourceBergen Drug Corporation reported $268.97 across General Payments, Research, and Ownership to 3 physicians and teaching hospitals across 3 transactions.
- $268.97 Below-median payer
- All-tracks total
- 3 Below-median volume
- Transactions
- 3 Below-median reach
- Recipients
- #1893
- of 1,925 companies
AmerisourceBergen Drug Corporation reported $268.97 across all CMS Open Payments tracks (General + Research + Ownership) to 3 physicians and teaching hospitals in Program Year 2024 - ranking #1893 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $268.97, averaging $89.66 per recipient.
AmerisourceBergen Drug Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer amerisourcebergen-drug-corporation AmerisourceBergen Drug Corporation
$268.97 · #1893/1,925 · 0.0% industry · PY2024
- TOT $268.97
- RANK #1893
- SHARE 0.0%
- TXN 3
- RCP 3
- CAT 1
- GEN $268.97
- TOP1 76.0%
- PY 2024
Volume peers
Nearest volume peer: McKesson Specialty Care Distribution, LLC ($271.93)
AmerisourceBergen Drug Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for AmerisourceBergen Drug Corporation
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For AmerisourceBergen Drug Corporation that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
3 transactions worth $268.97 make "Food and Beverage" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads AmerisourceBergen Drug Corporation's 1-category general-payment breakdown at $268.97, 100.0% of the reported total.
How AmerisourceBergen Drug Corporation divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $268.97 | 3 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $268.97 (100.0%) of $268.97 in this company's General Payments records across 3 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for AmerisourceBergen Drug Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Luis Campos
$204.46 across 1 reported transactions
- 2
Stephanie Gill
$32.26 across 1 reported transactions
- 3
Cody Griffin
$32.25 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
AmerisourceBergen Drug Corporation ranks #1893 of 1,925 by total payments (bottom 2% by spend) but is notably more concentrated than that alone would suggest -- #264 of 1,838 by HHI (top 14% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Optos plc : $31.7K total payments, HHI 6181
- Reliance Medical Systems : $945.25 total payments, HHI 6160
- Spinal Surgical Strategies, Inc. : $108.52 total payments, HHI 6125
- Southern Spine, LLC : $4.8K total payments, HHI 6122
- Quest Medical Inc. : $314.09 total payments, HHI 6093
- Carestream Health, Inc. : $84.2K total payments, HHI 6080
- AmerisourceBergen Drug Corporation (this company) : $268.97 total payments, HHI 6066
- pharmaand GmbH : $12.7K total payments, HHI 5994
- Viseon, Inc. : $146.3K total payments, HHI 5966
- Digital Diagnostics Inc. : $54.4K total payments, HHI 5924
- Vertical Orthopaedics, Inc. : $34.2K total payments, HHI 5923
- TheraMicro, Inc. : $14.0K total payments, HHI 5918
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as AmerisourceBergen Drug Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about AmerisourceBergen Drug Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with AmerisourceBergen Drug Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Materialise USA LLC
PARI Respiratory Equipment, Inc.
Fresenius USA Inc.
Voximetry, Inc.
Angelus Industria de Produtos Odontologicos S.A.
Put this to use
AmerisourceBergen Drug Corporation ranks #1893 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just AmerisourceBergen Drug Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.